Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death. - Conradt L; Henrich A; Wirth M; Reichert M; Lesina M; Algül H; Schmid RM; Krämer OH; Saur D; Schneider G (International journal of cancer, 2013)